Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02719158 · ClinicalTrials.gov registry record · Phase 2
Dose Ranging Study of OTO-201 in AOMT
A Phase 2 study, sponsored by Otonomy.
- Completed
- Registry status
- Phase 2
- Development phase
- 95
- Enrollment target
NCT02719158: Completed Phase 2 study, sponsored by Otonomy.
NCT02719158 is a Phase 2 study that has completed, run by Otonomy. The registered enrollment target is 95 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (29% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02719158, a Phase 2 study, has completed, sponsored by Otonomy.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 95 participants
- Enrollment target
Study Summary
Dose Ranging Study of OTO-201 in AOMT
Primary Outcome
Number of subjects with adverse events during the study from dosing up to 1 month after dosing
Interventions
- OTHER Sham
- DRUG 12 mg ciprofloxacin
- DRUG 6 mg ciprofloxacin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2016-02 |
| Est. Completion | 2016-07 |
| Phase | Phase 2 |
What the finished NCT02719158 record still lists
NCT02719158 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 95 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (29% lower).
The record links to 0 conditions, and to 3 interventions - of which Sham is the first listed.
NCT02719158 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02719158 about?
NCT02719158 is a clinical study titled "Dose Ranging Study of OTO-201 in AOMT". Dose Ranging Study of OTO-201 in AOMT
What is the current status of trial NCT02719158?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 95 participants. The study started on 2016-02. Estimated completion is 2016-07.
What interventions are being tested in trial NCT02719158?
The interventions under investigation include: Sham (OTHER), 12 mg ciprofloxacin (DRUG), 6 mg ciprofloxacin (DRUG).
Who is sponsoring clinical trial NCT02719158?
This trial is sponsored by Otonomy, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02719158's enrollment target sits among peer trials
95 759th of 2000 higher than 1,237 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03339128 · 95 participants · Phase 2
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children
- NCT03509961 · 95 participants · Phase 2
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
- NCT03694756 · 95 participants · NA
TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer
- NCT04206215 · 95 participants · NA
Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia